UTHealth's Center for Neurobehavioral Research on Addictions opens outpatient clinic

An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston (UTHealth).

The clinic's program, Multidisciplinary Outpatient Intensive Treatment (MOTIVATE), will treat persons with addictive disorders including smoking, alcoholism, the use of illegal substances and the abuse of prescription medications.

"Our treatment for addictions combines pharmacological interventions with behavioral therapy. Studies have shown that when you do the two together, the results are superior," said the center's co-director, Joy Schmitz, Ph.D., professor of psychiatry and behavioral sciences at The UTHealth Medical School.

Schmitz said treatments will draw on the research carried out at "Centers of Excellence" such as UTHealth's CNRA, funded by the National Institute on Drug Abuse, part of National Institutes of Health.

"This allows us to transfer our technology and research to the next step, such as the use of medication for cocaine addiction," said F. Gerald Moeller, M.D., the Louis A. Faillace Professor of Psychiatry and director of the CNRA and the clinic. "For example, we have published results showing that a medication prescribed for depression reduces cocaine use in some people with cocaine addiction, even if they don't have depression."

The clinic's team approach includes licensed professional counselors and physicians. Moeller, Schmitz and Joel Steinberg, M.D., associate professor of psychiatry and behavioral sciences, will be among the staff treating patients. The clinic is part of UT Physicians, the medical practice of the UTHealth Medical School.

"The treatment plan at MOTIVATE is individually tailored, based on results of an initial and comprehensive medical, psychiatric and behavioral evaluation," Schmitz said. "We know that addiction is not just about taking a drug. It affects so many areas of functioning."

After the medical and psychiatric screening, patients will be seen at the clinic twice a week over a 12-week period. Post-treatment recommendations will follow, including options for extending the MOTIVATE program.

Source: The University of Texas Health Science Center at Houston

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how antimicrobial exposure affects Parkinson’s disease risk